JNJ reported ~$17.8 billion in revenues in 1Q17, registering a YoY sales growth of around 1.6%. Its Medical Device segment reported ~3% growth.
JNJ’s new product launches, acquisitions, and collaborations contributed significantly to its Medical Devices segment’s sales.
ConocoPhillips (COP) announced the news of its Canada asset divestitures before the market opened on June 29, 2017.
ConocoPhillips’s (COP) Barnett assets have a relatively small contribution to its overall production. In 2016, COP’s Barnett assets produced only 11 MBoepd.
On June 29, 2017, ConocoPhillips announced its agreement with an affiliate of Miller Thomson & Partners to sell its upstream assets located in the Barnett Basin.
On June 29, Microsoft confirmed news that it would be acquiring Cloudyn, an Israel-based cybersecurity firm.
Varian Medical Systems (VAR) was trading at $102.7 on June 29, 2017. It has a 50-day moving average of $100.4 and a 200-day moving average of $88.8.
On June 29, 2017, Varian Medical Systems announced the FDA’s 510(k) clearance for its Halcyon Treatment System. The device is used for IMRT treatment.
On June 29, 2017, Walgreens Boots Alliance (WBA) and Rite Aid (RAD) announced that they have a new definitive agreement.
On June 13, 2017, Zimmer Biomet (ZBH) announced that the FDA warning letter issued in June 2015 relating to its Zhejiang manufacturing facility in China has been closed.
Zimmer Biomet Holdings (ZBH) announced a quarterly cash dividend of $0.24 per share on May 30, 2017, for 2Q17, payable on July 28, 2017.
On June 28, 2017, Zimmer Biomet announced the launch of its X-PSI Knee System, an X-ray–based surgical system that allows patient-specific implant positioning.
Boston Scientific’s Alair Bronchial Thermoplasty System is used to treat patients suffering from severe asthma.
On June 6, 2017, Boston Scientific (BSX) announced the company had received CE Mark approval for its Vercise Gevia DBS (deep brain stimulation) systems.
The deal will improve Walgreens’ physical reach across the US, especially in the Northeast, and increase its store count more than 25%.
On June 29, 2017, Walgreens Boots Alliance (WBA) and Rite Aid (RAD) announced a new definitive agreement. Walgreens will purchase 2,186 Rite Aid stores.
Abbott Laboratories (ABT) reported about $1.6 billion of revenues from its Nutrition segment, representing a YoY (year-over-year) fall of ~1.0%.
Abbott Laboratories completed the acquisition of St. Jude Medical in January 2017. The integration has been on track.
On May 9, 2017, Abbott Laboratories (ABT) announced that it received CE Marking for its sensor-enabled TactiCath Contact Force Ablation Catheter.
On May 8, 2017, Abbott Laboratories (ABT) announced the CE Marking approval of its Confirm Rx ICM. ABT stock rose 0.09% that day.